OTCMKTS:NBHGF

Nobel Biocare (NBHGF) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$18.25
$18.25
50-Day Range
N/A
52-Week Range
$16.35
$19.50
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About Nobel Biocare

NBHGF Stock News Headlines

Protect Your Bank Account Before It’s Too Late
For months I’ve been warning about the federal government’s terrifying new program to control every American’s bank account. It gives them the power to monitor every single transaction …
Will There Be A Nobel Prize For AI?
Protect Your Bank Account Before It’s Too Late
For months I’ve been warning about the federal government’s terrifying new program to control every American’s bank account. It gives them the power to monitor every single transaction …
What to Know About the 2023 Nobel Prizes
Nobel Economist Krugman Calls Out Venmo
See More Headlines
Receive NBHGF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nobel Biocare and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
8/21/2014
Today
5/02/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Dental Equipment & Supplies
Sub-Industry
N/A
Current Symbol
OTCMKTS:NBHGF
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
-0.01
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for May 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

NBHGF Stock Analysis - Frequently Asked Questions

How were Nobel Biocare's earnings last quarter?

Nobel Biocare Ag (OTCMKTS:NBHGF) released its quarterly earnings data on Thursday, August, 21st. The company reported $0.17 EPS for the quarter, topping analysts' consensus estimates of $0.12 by $0.05. The firm had revenue of $191.67 million for the quarter, compared to analyst estimates of $171.79 million.

This page (OTCMKTS:NBHGF) was last updated on 5/2/2024 by MarketBeat.com Staff

From Our Partners